Editorial
Copyright ©The Author(s) 2024.
World J Diabetes. Jun 15, 2024; 15(6): 1074-1078
Published online Jun 15, 2024. doi: 10.4239/wjd.v15.i6.1074
Table 1 Comparative analysis of studies on serum bilirubin and γ-glutamyltransferase levels in cardiovascular diseases based on their geography, cohort size
Ref.
Country
Sample size
Heart disease
Level of γ-GGT
Level of bilirubin
Citation journal
Year
Ruttmann et al[4]Austria163944Various CVDsSignificantly associated with CVD mortality-Circulation2005
Emiroglu et al[2]TurkeyACS: 219; Control: 51Acute coronary syndromeHigher in ACS patients-Acta Diabetol2010
Fukui et al[8]-633T2DM-Inversely correlated with albuminuria and subclinical atherosclerosisKidney Int2008
Dalos et al[3]-HFpEF: 274Heart failure with preserved ejection fractionIndependently associated with outcome-Sci Rep2019
Passamonti et al[10]----Present in endothelial cells, antioxidative capacityMeta Gene2018
Lin et al[9]----Inversely associated with CVD and related diseasesClinical Chemistry2010
Cho et al[5]Korea9687066General CVDIncreased levels associated with all-cause and CVD mortality-Sci Rep2023
Baek et al[6]Korea1640127Myocardial infarction, stroke, CVDCumulative high levels associated with increased CVD risk-Endocrinol Metab (Seoul)2023
Chen et al[1]ChinaT2DM + ACS: 96; T2DM: 85; ACS: 90ACSIncreased in T2DM + ACSProtective factorWorld J Diabetes2023